4.7 Review

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Microbiology

Akkermansia muciniphila plays critical roles in host health

Qixiang Zhao et al.

Summary: Akkermansia muciniphila, a common intestinal microorganism, affects host health through mucin degradation, including consolidating the intestinal barrier and regulating metabolic and immune functions.

CRITICAL REVIEWS IN MICROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila

Li Zhang et al.

Summary: MDG, derived from Ophiopogon japonicus, has a protective effect against obesity and nonalcoholic fatty liver disease (NAFLD). This study found that MDG supplementation improved lipid accumulation, liver steatosis, and chronic inflammation in NAFLD mice induced by a high-fat diet. It also increased the abundance and diversity of gut microbial communities. The results suggest that MDG treatment can inhibit obesity and the NAFLD process by modulating lipid-related pathways and altering the structure and diversity of gut microbiota.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Endocrinology & Metabolism

Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease

Chander K. Negi et al.

Summary: NAFLD is the most common form of chronic liver disease worldwide, with current treatment options including dietary restrictions and lifestyle modification. It is closely associated with metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia, with various pharmacological approaches being considered in clinical management.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Article Gastroenterology & Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey Lazarus et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects a significant portion of the global adult population, but has received little attention from the global public health community. This has led to a lack of inclusion of NAFLD in national and international strategies and policies for non-communicable diseases, highlighting the need for a more comprehensive public health response to the disease.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Multidisciplinary Sciences

The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury

Shahrbanoo Keshavarz Azizi Raftar et al.

Summary: Akkermansia muciniphila and its derivatives can improve inflammatory liver injury by enhancing intestinal integrity and anti-inflammatory responses. Live A. muciniphila and its extracellular vesicles have stronger anti-inflammatory effects on liver and adipose tissues.

SCIENTIFIC REPORTS (2022)

Review Gastroenterology & Hepatology

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

Patrice D. Cani et al.

Summary: This article reviews the discovery of Akkermansia muciniphila and its association with health and disease. Studies have shown that A. muciniphila can improve health through various mechanisms and comparisons are made with other next-generation beneficial microorganisms.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium

Jiyeon Si et al.

Summary: Despite its short history, Akkermansia muciniphila has shown potential effects on human health and metabolism. It strengthens gut integrity, modulates insulin resistance, and protects against metabolic inflammation. However, further research is needed to fully understand its molecular mechanisms and potential drawbacks.

GUT MICROBES (2022)

Article Multidisciplinary Sciences

Akkermansia muciniphila phospholipid induces homeostatic immune responses

Munhyung Bae et al.

Summary: This study identifies a lipid molecule from Akkermansia muciniphila's cell membrane that exhibits immunomodulatory activity through the Toll-like receptor TLR2-TLR1 pathway. The findings provide molecular insights into the role of Akkermansia muciniphila in regulating immune balance and its impact on health and disease.

NATURE (2022)

Article Microbiology

TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

Yaojiang Liu et al.

Summary: TLR4 plays a protective role in preventing intestinal inflammation by modulating immune responses associated with A. muciniphila. This finding provides a new perspective on host-commensal symbiosis and may contribute to the development of potential therapeutic strategies.

MICROBIOME (2022)

Article Pharmacology & Pharmacy

P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway

Xia Hua et al.

Summary: P7C3-A20 can alleviate NAFLD by stimulating FGF21 and FGF1, promoting gut microbiota balance, and reducing metabolic abnormalities and inflammation.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Cell Biology

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

S. R. Sharpton et al.

Summary: Nonalcoholic fatty liver disease (NALFD) is a leading cause of chronic liver disease worldwide, associated with rapidly rising levels of obesity and metabolic syndrome, and is a major risk factor for cirrhosis, hepatocellular carcinoma, and liver-related mortality. The gut microbiome is intricately linked to the pathogenesis of NAFLD, and can be leveraged for personalized disease management strategies.

CELL METABOLISM (2021)

Article Gastroenterology & Hepatology

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Na Young Lee et al.

Summary: The study found that NAFLD patients have abnormal composition of gut microbiota, and intake of Lactobacillus (such as L. acidophilus) can lower cholesterol levels and improve the progression of NAFLD.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Article Plant Sciences

Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota

Ruiting Han et al.

Summary: Si Miao Formula (SMF) alleviated HFHS diet-induced NAFLD in mice by reducing hepatic steatosis, body weight gain, and improving insulin sensitivity and glucose tolerance. SMF downregulated fatty acid biosynthesis and stimulated the insulin secretion pathway in the liver, while also altering gut microbiota composition, particularly increasing the abundance of Akkermansia muciniphila. These findings indicate that SMF possesses potential anti-NAFLD effects through modulation of hepatic lipid metabolism pathways and gut microbiota composition.

PHYTOMEDICINE (2021)

Article Microbiology

Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice

Zunji Shi et al.

Summary: The consumption of saccharin/sucralose alters gut microbial community structure, leading to depletion of Akkermansia muciniphila and development of NAFLD in mice. Metformin or fructo-oligosaccharide supplementation can help restore gut microbiota balance and alleviate NAFLD. A new potential nutritional strategy involves using neohesperidin dihydrochalcone as a substitute for artificial sweeteners and free sugars.

MSYSTEMS (2021)

Article Immunology

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease

Xiongfeng Pan et al.

Summary: This case-control study aimed to investigate the role of gut microbiota, especially butyrate-producing bacteria, in children with NAFLD. The results showed that children with NAFLD had dysbiosis in glucose, lipid, and water-electrolyte metabolism, with decreased abundance of beneficial bacteria and increased harmful bacteria in their gut microbiome. This suggests that the gut microbiome composition plays a significant role in the development and severity of NAFLD in children.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice

Xueliang Wang et al.

Summary: Treatment with PYOs significantly improved NAFLD by reducing oxidative stress, inflammation, hepatic lipid accumulation, and fibrosis through specific molecular mechanisms, as well as reshaping the cecal microbiota to protect the liver.

FASEB JOURNAL (2021)

Article Biochemistry & Molecular Biology

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation

Maria Juarez-Fernandez et al.

Summary: The combination of the antioxidant quercetin and the bacterium Akkermansia muciniphila in an animal model of early obesity and NAFLD can modulate gut microbiota, reduce body fat, improve fatty liver, increase the abundance of beneficial bacteria, decrease the levels of harmful bacteria, raise bile acids levels, and enhance the expression of liver genes related to bile acid metabolism.

ANTIOXIDANTS (2021)

Article Microbiology

Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation

Siwen Qu et al.

Summary: Akkermansia muciniphila has been shown to play a crucial role in the progression of colitis, with its protective effects in acute colitis depending on NLRP3 activation. This study enriches the understanding of the mechanisms underlying A. muciniphila's effects and offers a new prospect for probiotic-based treatments of colitis. The interaction between gut microbiota and host immune response plays a significant role in intestinal inflammatory diseases.

MICROBIOLOGY SPECTRUM (2021)

Review Gastroenterology & Hepatology

AHR in the intestinal microenvironment: safeguarding barrier function

Brigitta Stockinger et al.

Summary: The Aryl hydrocarbon receptor (AHR) signaling pathway plays significant roles in the intestine, regulating various cell types and impacting inflammation and tumorigenesis. AHR is a ligand-dependent transcription factor that translocates to the nucleus upon ligand binding, where it interacts with other proteins to modulate gene expression. Research has shown that AHR not only responds to environmental pollutants, but also serves important beneficial functions in immune, epithelial, endothelial, and neuronal cells within the intestinal microenvironment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Microbiology

Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice

Hyo Shin Yoon et al.

Summary: The study demonstrates that Akkermansia muciniphila increases thermogenesis and GLP-1 secretion in mice by inducing uncoupling protein 1. A protein secreted by A. muciniphila, P9, interacts with ICAM-2 and can target metabolic diseases. This interaction could be a potential therapeutic target for such diseases.

NATURE MICROBIOLOGY (2021)

Article Health Care Sciences & Services

Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients

Hui-Ju Tsai et al.

Summary: This study found a positive correlation between the abundance of Firmicutes phylum and the severity of NAFLD in T2D patients. The gut microbiota, specifically Firmicutes, could potentially serve as a predictor for NAFLD severity in T2D patients.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Medicine, Research & Experimental

The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis

Hou Wang et al.

Summary: Liraglutide was found to alleviate lipid-induced hepatic steatosis by activating the HIF-2 alpha/PPAR alpha pathway, with significant improvements in various indicators in WT mice but not in HIF-2 alpha(+/-) mice.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Microbiology

Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children

Kattayoun Kordy et al.

Summary: The study found that children with more severe liver pathology in non-alcoholic fatty liver disease had more dysbiosis in their microbiota and disturbances in various metabolic pathways. Non-targeted mass spectrometry analysis revealed metabolic perturbations in one-carbon metabolism, mitochondrial dysfunction, and oxidative stress in these children.

FRONTIERS IN MICROBIOLOGY (2021)

Article Microbiology

The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury

Shahrbanoo Keshavarz Azizi Raftar et al.

Summary: The study demonstrated that A. muciniphila and its EVs protect against HSC activation while improving liver fibrosis biomarkers, reducing liver histopathological damage, and modulating gut microbiota composition.

MICROBIOLOGY SPECTRUM (2021)

Review Gastroenterology & Hepatology

Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?

Juan Yan et al.

Summary: This paper provides a systemic review of the effects and mechanisms of Akkermansia muciniphila and its components in treating metabolic diseases such as obesity, type 2 diabetes mellitus, cardiovascular disease, and nonalcoholic fatty liver disease, as well as insights into future studies.

GUT MICROBES (2021)

Article Gastroenterology & Hepatology

Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats

Sara G. Higarza et al.

Summary: This study explores the impact of environmental enrichment and the administration of Lacticaseibacillus rhamnosus GG (LGG) or Akkermansia muciniphila CIP107961 (AKK) on cognitive dysfunction related to nonalcoholic steatohepatitis (NASH). It was found that AKK and EE were effective in reversing cognitive impairment induced by a high-fat, high-cholesterol diet, with differences in their effects on brain metabolism. Furthermore, AKK and LGG did not significantly alter the intestinal microbiota composition, while EE led to an increase in certain microbial members.

GUT MICROBES (2021)

Article Biochemistry & Molecular Biology

Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis

Zhenyang Gu et al.

Summary: The study suggests that the probiotic Akkermansia muciniphila (Akk) may alleviate ulcerative colitis (UC) by regulating tryptophan (Trp) metabolism, suppressing the kynurenine pathway (KP) independently of colon tissue, and promoting Trp metabolism enrichment mediated by fecal microbiota.

FOOD & FUNCTION (2021)

Article Gastroenterology & Hepatology

Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development

Seungil Kim et al.

Summary: Mucin-degrading bacteria, such as A. muciniphila, can promote the proliferation of intestinal stem cells and differentiation of specific cell types in the small intestine and colon. Additionally, treatment with A. muciniphila leads to higher levels of acetic and propionic acids in the cecal contents of mice. Furthermore, pre-treatment with A. muciniphila can reduce gut damage caused by radiation and methotrexate, suggesting a potential role in intestinal homeostasis maintenance.

GUT MICROBES (2021)

Article Gastroenterology & Hepatology

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Yong Rao et al.

Summary: Akkermansia muciniphila has therapeutic potential in treating metabolic disorders such as NAFLD, with mechanisms involving increased mitochondrial oxidation, bile acid metabolism, and reshaping of gut microbiota composition. Additionally, the regulation of L-aspartate metabolism contributes to the beneficial effects on MAFLD.

GUT MICROBES (2021)

Article Gastroenterology & Hepatology

Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family

Jingjing Du et al.

Summary: Betaine can prevent obesity and metabolic syndrome by improving gut microbiota dysbiosis. Akkermansia muciniphila plays a crucial role in regulating the effects of betaine and increasing strains that produce short-chain fatty acids (SCFAs).

GUT MICROBES (2021)

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

Article Biotechnology & Applied Microbiology

Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis

Sejeong Kim et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?

Judith Aron-Wisnewsky et al.

GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD

Guido Carpino et al.

HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis

Jasmohan S. Bajaj et al.

JOURNAL OF HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

Daniel M. Chopyk et al.

GASTROENTEROLOGY (2020)

Review Cell Biology

The Gut Microbiota at the Service of Immunometabolism

Chloe Michaudel et al.

CELL METABOLISM (2020)

Article Pharmacology & Pharmacy

Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: Non-genomic and genomic signaling

Karl Walter Bock

BIOCHEMICAL PHARMACOLOGY (2020)

Article Biotechnology & Applied Microbiology

Effect of diet and intestinal AhR expression on fecal microbiome and metabolomic profiles

Fang Yang et al.

MICROBIAL CELL FACTORIES (2020)

Article Biochemistry & Molecular Biology

Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD

Kun Xie et al.

FOOD & FUNCTION (2020)

Article Gastroenterology & Hepatology

Burden of liver diseases in the world

Sumeet K. Asrani et al.

JOURNAL OF HEPATOLOGY (2019)

Review Biotechnology & Applied Microbiology

Akkermansia muciniphila is a promising probiotic

Ting Zhang et al.

MICROBIAL BIOTECHNOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome

Martha Guevara-Cruz et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Review Food Science & Technology

A next generation probiotic, Akkermansia muciniphila

Qixiao Zhai et al.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)

Review Medicine, Research & Experimental

The role of the microbiome in NAFLD and NASH

Aleksandra A. Kolodziejczyk et al.

EMBO MOLECULAR MEDICINE (2019)

Review Gastroenterology & Hepatology

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Konstantin Kazankov et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Lesley Hoyles et al.

NATURE MEDICINE (2018)

Review Biochemistry & Molecular Biology

Mechanisms of NAFLD development and therapeutic strategies

Scott L. Friedman et al.

NATURE MEDICINE (2018)

Editorial Material Gastroenterology & Hepatology

NAFLD IN 2017 Novel insights into mechanisms of disease progression

Reenam S. Khan et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Multidisciplinary Sciences

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice

Jane M. Natividad et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Liraglutide modulates gut microbiota and reduces NAFLD in obese mice

G. V. Moreira et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)

Review Endocrinology & Metabolism

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease

Jingjing Cai et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)

Article Gastroenterology & Hepatology

Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice

Heetae Lee et al.

GUT MICROBES (2018)

Article Biochemistry & Molecular Biology

Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions

Chaithanya Chelakkot et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Article Endocrinology & Metabolism

Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice

Shaoqian Zhao et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)

Review Immunology

Akkermansia muciniphila and its role in regulating host functions

Muriel Derrien et al.

MICROBIAL PATHOGENESIS (2017)

Article Biochemistry & Molecular Biology

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Ruixin Liu et al.

NATURE MEDICINE (2017)

Article Gastroenterology & Hepatology

Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis

Ceren Ozkul et al.

TURKISH JOURNAL OF GASTROENTEROLOGY (2017)

Article Multidisciplinary Sciences

Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity

Pegah Mehrpouya-Bahrami et al.

SCIENTIFIC REPORTS (2017)

Review Gastroenterology & Hepatology

The role of the gut microbiota in NAFLD

Christopher Leung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Genetics & Heredity

Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes

Moran Yassour et al.

GENOME MEDICINE (2016)

Article Microbiology

The microenvironment of injured murine gut elicits a local pro-restitutive microbiota

Ashfaqul Alam et al.

NATURE MICROBIOLOGY (2016)

Article Gastroenterology & Hepatology

Hepatic TLR4 signaling in obese NAFLD

Torfay Sharifnia et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)

Article Endocrinology & Metabolism

Specific gut microbiota features and metabolic markers in postmenopausal women with obesity

L. K. Brahe et al.

NUTRITION & DIABETES (2015)

Article Medicine, Research & Experimental

Is serum Interleukin-17 associated with early atherosclerosis in obese patients?

Giovanni Tarantino et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

Article Multidisciplinary Sciences

Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

Xiuying Zhang et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

Amandine Everard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Endocrinology & Metabolism

Non-alcoholic steatohepatitis: a microbiota-driven disease

Alexander R. Moschen et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)

Article Gastroenterology & Hepatology

The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

Herbert Tilg

DIGESTIVE DISEASES (2010)

Review Biochemistry & Molecular Biology

Glucagon-like peptide-1, glucose homeostasis and diabetes

Jens J. Holst et al.

TRENDS IN MOLECULAR MEDICINE (2008)

Article Biotechnology & Applied Microbiology

The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract

Muriel Derrien et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)

Article Endocrinology & Metabolism

Adiponectin: action, regulation and association to insulin sensitivity

AS Lihn et al.

OBESITY REVIEWS (2005)

Article Microbiology

Akkermansia muciniphila gen. nov., sp nov., a human intestinal mucin-degrading bacterium

M Derrien et al.

INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2004)